Patents by Inventor Tomoka Nagasato

Tomoka Nagasato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240060999
    Abstract: A method of analyzing blood coagulation in vitro, comprising analyzing blood coagulation ability using a blood sample in which an extrinsic blood coagulation activator, thrombomodulin and a heparin-like substance are added.
    Type: Application
    Filed: December 28, 2021
    Publication date: February 22, 2024
    Applicant: FUJIMORI KOGYO CO., LTD
    Inventors: Kazuya HOSOKAWA, Tomoka NAGASATO, Hisayo KANEKO, Chiaki OYAMADA, Tomoko WADA
  • Publication number: 20240024875
    Abstract: A method for manufacturing a microchip for a blood coagulation test includes preparing a substrate which has, in the surface thereof, a groove serving as a flow channel, and has a first through-hole serving as an inlet and provided on one end side of the groove. A film having a surface coated with collagen and/or tissue thromboplastin is prepared so as to cover a region of a portion on the flow channel when the film is bonded to the surface, of the substrate, having the groove therein overlaps the surface, of the film, coated with the collagen and/or tissue thromboplastin.
    Type: Application
    Filed: November 26, 2021
    Publication date: January 25, 2024
    Inventors: Masato ABE, Takao SATO, Tomoko WADA, Tomoka NAGASATO, Kazuya HOSOKAWA
  • Patent number: 11480559
    Abstract: A method for analyzing thrombogenic capacity or blood coagulation capacity, the method comprising adding calcium, a blood coagulation factor XII (FXII) inhibitor, and a kallikrein inhibitor to blood collected with a blood collection tube containing sodium citrate, to allow initiation of blood coagulation reaction, is provided. Preferably, heparin, heparan sulfate, and tissue factor are further added to the blood, and thrombogenic capacity or blood coagulation capacity is analyzed.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: October 25, 2022
    Assignee: FUJIMORI KOGYO CO., LTD.
    Inventors: Kazuya Hosokawa, Tomoko Wada, Hisayo Kaneko, Takaaki Hasegawa, Tomoka Nagasato
  • Publication number: 20190004031
    Abstract: A method for analyzing thrombogenic capacity or blood coagulation capacity, the method comprising adding calcium, a blood coagulation factor XII (FXII) inhibitor, and a kallikrein inhibitor to blood collected with a blood collection tube containing sodium citrate, to allow initiation of blood coagulation reaction, is provided. Preferably, heparin, heparan sulfate, and tissue factor are further added to the blood, and thrombogenic capacity or blood coagulation capacity is analyzed.
    Type: Application
    Filed: January 6, 2017
    Publication date: January 3, 2019
    Inventors: Kazuya Hosokawa, Tomoko Wada, Hisayo Kaneko, Takaaki Hasegawa, Tomoka Nagasato